Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Details

Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications

FDA-2026-N-4291-0001Notice
Document

Details

The document's own metadata, straight from the source system.

Title
Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications
Posted
May 7, 2026
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗